BiotechTube
Home/AMT Medical/Geert van Gansewinkel
GV

Geert van Gansewinkel

Chief Executive Officer

AMT Medical

Therapeutic Areas

Cardiovascular DiseaseCoronary Artery Disease

AMT Medical Pipeline

DrugIndicationPhase
Elana® Anastomotic System for CABGCoronary Artery Bypass Graft (CABG) SurgeryDevelopment/Pre-market

Leadership Team at AMT Medical

RT
Rutger Tulleken
Founder and strategic advisor
TH
Taco Houwert
Chief Strategy Officer
GB
Glenn Bronkers
Chief Technical Officer
RD
Ruairi Duffy
Design and Development Director
MA
Maarten Arends
Director Quality & Regulatory
RS
Ralf Slag
Manufacturing Manager
PD
Prof. dr. Volkmar Falk
Clinical Advisor
PD
Prof. dr. Bas de Mol
Clinical Advisor
View full AMT Medical profile